These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Bacteremia in children at a regional hospital in Trinidad. Orrett FA; Changoor E Int J Infect Dis; 2007 Mar; 11(2):145-51. PubMed ID: 16787754 [TBL] [Abstract][Full Text] [Related]
23. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae. Jones RN; Sader HS; Stilwell MG; Fritsche TR Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904 [TBL] [Abstract][Full Text] [Related]
24. Epidemiology, clinical characteristics and antimicrobial resistance patterns of community-acquired pneumonia in 1702 hospitalized children in Singapore. Chiang WC; Teoh OH; Chong CY; Goh A; Tang JP; Chay OM Respirology; 2007 Mar; 12(2):254-61. PubMed ID: 17298459 [TBL] [Abstract][Full Text] [Related]
25. The etiology of community-acquired pneumonia at an urban public hospital: influence of human immunodeficiency virus infection and initial severity of illness. Park DR; Sherbin VL; Goodman MS; Pacifico AD; Rubenfeld GD; Polissar NL; Root RK; J Infect Dis; 2001 Aug; 184(3):268-77. PubMed ID: 11443551 [TBL] [Abstract][Full Text] [Related]
27. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era. Madeddu G; Porqueddu EM; Cambosu F; Saba F; Fois AG; Pirina P; Mura MS Infection; 2008 Jun; 36(3):231-6. PubMed ID: 18463787 [TBL] [Abstract][Full Text] [Related]
28. Pneumocystis pneumonia in South African children with and without human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Morrow BM; Hsaio NY; Zampoli M; Whitelaw A; Zar HJ Pediatr Infect Dis J; 2010 Jun; 29(6):535-9. PubMed ID: 20072079 [TBL] [Abstract][Full Text] [Related]
29. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Wang JL; Chen SY; Wang JT; Wu GH; Chiang WC; Hsueh PR; Chen YC; Chang SC Clin Infect Dis; 2008 Mar; 46(6):799-806. PubMed ID: 18266610 [TBL] [Abstract][Full Text] [Related]
30. Community-acquired bacteremia among children admitted to a rural hospital in Mozambique. Sigaúque B; Roca A; Mandomando I; Morais L; Quintó L; Sacarlal J; Macete E; Nhamposa T; Machevo S; Aide P; Bassat Q; Bardají A; Nhalungo D; Soriano-Gabarró M; Flannery B; Menendez C; Levine MM; Alonso PL Pediatr Infect Dis J; 2009 Feb; 28(2):108-13. PubMed ID: 19131902 [TBL] [Abstract][Full Text] [Related]
31. High nasopharyngeal carriage of drug resistant Streptococcus pneumoniae and Haemophilus influenzae in North Indian schoolchildren. Jain A; Kumar P; Awasthi S Trop Med Int Health; 2005 Mar; 10(3):234-9. PubMed ID: 15730507 [TBL] [Abstract][Full Text] [Related]
32. Community-acquired bacteremia in human immunodeficiency virus-infected children in Harare, Zimbabwe. Nathoo KJ; Chigonde S; Nhembe M; Ali MH; Mason PR Pediatr Infect Dis J; 1996 Dec; 15(12):1092-7. PubMed ID: 8970218 [TBL] [Abstract][Full Text] [Related]
33. Severe lower respiratory tract infections associated with human parainfluenza viruses 1-3 in children infected and noninfected with HIV type 1. Madhi SA; Ramasamy N; Petersen K; Madhi A; Klugman KP Eur J Clin Microbiol Infect Dis; 2002 Jul; 21(7):499-505. PubMed ID: 12172740 [TBL] [Abstract][Full Text] [Related]
34. Impact of HIV-1 co-infection on presentation and hospital-related mortality in children with culture proven pulmonary tuberculosis in Durban, South Africa. Jeena PM; Pillay P; Pillay T; Coovadia HM Int J Tuberc Lung Dis; 2002 Aug; 6(8):672-8. PubMed ID: 12150478 [TBL] [Abstract][Full Text] [Related]
35. Gender as a risk factor for both antibiotic resistance and infection with pediatric serogroups/serotypes, in HIV-infected and -uninfected adults with pneumococcal bacteremia. Buie KA; Klugman KP; von Gottberg A; Perovic O; Karstaedt A; Crewe-Brown HH; Madhi SA; Feldman C J Infect Dis; 2004 Jun; 189(11):1996-2000. PubMed ID: 15143465 [TBL] [Abstract][Full Text] [Related]
36. Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin. Appelbaum PC; Gillespie SH; Burley CJ; Tillotson GS Int J Antimicrob Agents; 2004 Jun; 23(6):533-46. PubMed ID: 15194123 [TBL] [Abstract][Full Text] [Related]
37. Nosocomial bacterial pneumonia in HIV-infected patients: risk factors for adverse outcome and implications for rational empiric antibiotic therapy. Franzetti F; Grassini A; Piazza M; Degl'innocenti M; Bandera A; Gazzola L; Marchetti G; Gori A Infection; 2006 Feb; 34(1):9-16. PubMed ID: 16501896 [TBL] [Abstract][Full Text] [Related]
38. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients. Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683 [TBL] [Abstract][Full Text] [Related]
39. Different clinical presentation of community-onset bacteremia among human immunodeficiency virus-infected and human immunodeficiency virus-uninfected adults in the ED. Lee CC; Chu FY; Ko WC; Chi CH Am J Emerg Med; 2014 Oct; 32(10):1241-7. PubMed ID: 25171801 [TBL] [Abstract][Full Text] [Related]
40. [Bacteremic pneumococcal pneumonia]. Pineda Solas V; Pérez Benito A; Domingo Puiggros M; Larramona Carrera H; Segura Porta F; Fontanals Aymerich D An Esp Pediatr; 2002 Nov; 57(5):408-13. PubMed ID: 12467543 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]